🔗 Permalink

Inventor profile of:

Daniel M. Canafax

City:

Half Moon Bay, California

Country:

United States

Published Applications:

Last publication date:

2026-04-09

Top Assignees for applications by Daniel M. Canafax

The entities that hold a legal rights for patent applications filed by inventor Canafax Daniel M.:

XWPHARMA LTD. 11 Grand Cayman, Cayman Islands
XENOPORT, INC. 2 Santa Clara, CA United States

Recent patent applications by Canafax Daniel M.

Daniel M. Canafax from Half Moon Bay, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-04-09

US20260097009A1

Human necessities

PHARMACOKINETICS OF COMBINED RELEASE FORMULATIONS OF A GAMMA-HYDROXYBUTYRIC ACID DERIVATIVE

#2 | 2025-11-20

US20250352496A1

Human necessities

PHARMACEUTICAL COMPOSITIONS AND ORAL DOSAGE FORMS OF KETAMINE DERIVATIVES

#3 | 2025-11-20

US20250352481A1

Human necessities

MODIFIED RELEASE COMPOSITIONS OF A GAMMA-HYDROXYBUTYRIC ACID DERIVATIVE

#4 | 2025-08-21

US20250262157A1

Human necessities

CONTROLLED RELEASE GRANULATIONS OF WATER-SOLUBLE ACTIVE PHARMACEUTICAL INGREDIENTS

#5 | 2025-02-06

US20250041425A1

Human necessities

EXCIPIENT GRANULATIONS

#6 | 2025-02-06

US20250041258A1

Human necessities

PHARMACEUTICAL COMPOSITIONS OF A GAMMA-HYDROXYBUTYRIC ACID DERIVATIVE

#7 | 2024-05-16

US20240156772A1

Human necessities

PHARMACOKINETICS OF COMBINED RELEASE FORMULATIONS OF A GAMMA-HYDROXYBUTYRIC ACID DERIVATIVE

#8 | 2024-05-16

US20240156741A1

Human necessities

MODIFIED RELEASE COMPOSITIONS OF A GAMMA-HYDROXYBUTYRIC ACID DERIVATIVE

#9 | 2024-04-25

US20240130996A1

Human necessities

PHARMACEUTICAL COMPOSITIONS AND PHARMACOKINETICS OF A GAMMA-HYDROXYBUTYRIC ACID DERIVATIVE

#10 | 2023-09-14

US20230285325A1

Human necessities

PHARMACEUTICAL COMPOSITIONS AND ORAL DOSAGE FORMS OF KETAMINE DERIVATIVES

#11 | 2023-03-30

US20230098084A1

Human necessities

Pharmaceutical compositions and oral dosage forms of ketamine derivatives

#12 | 2023-03-02

US20230067371A1

Human necessities

Pharmacokinetics of combined release formulations of a gamma-hydroxybutyric acid derivative

#13 | 2022-10-13

US20220323366A1

Human necessities

PHARMACEUTICAL GRANULATIONS OF WATER-SOLUBLE ACTIVE PHARMACEUTICAL INGREDIENTS

#14 | 2022-10-13

US20220323365A1

Human necessities

Modified release compositions of a GAMMA-hydroxybutyric acid derivative

#15 | 2022-09-29

US20220304969A1

Human necessities

Pharmacokinetics of combined release formulations of a γ-hydroxybutyric acid derivative

#16 | 2022-06-16

US20220183977A1

Human necessities

CONTROLLED RELEASE GRANULATIONS OF WATER-SOLUBLE ACTIVE PHARMACEUTICAL INGREDIENTS

#17 | 2022-04-07

US20220105044A1

Human necessities

Modified release compositions of a gamma-hydroxybutyric acid derivative

#18 | 2022-01-27

US20220023247A1

Human necessities

Pharmaceutical compositions and pharmacokinetics of a gamma-hydroxybutyric acid derivative

#19 | 2021-12-23

US20210393537A1

Human necessities

Pharmaceutical granulations of water-soluble active pharmaceutical ingredients

#20 | 2021-12-23

US20210393529A1

Human necessities

Controlled release granulations of water-soluble active pharmaceutical ingredients

#21 | 2011-03-10

US20110060040A1

Human necessities

USES OF ACYLOXYALKYL CARBAMATE PRODRUGS OF TRANEXAMIC ACID

#22 | 2009-05-07

US20090118365A1

Human necessities

Use of Prodrugs of GABA B Agonists for Treating Neuropathic and Musculoskeletal Pain

#23 | 2005-09-01

US20050192353A1

Human necessities

Treating or preventing restless legs syndrome using prodrugs of GABA analogs

InventorID:

3523747 ⎘